Description
Uses of Medicine:
Imatinib 100 mg/400 mg is a tyrosine kinase inhibitor (TKI). Patients, Healthcare Professionals (HCP), or Hospitals can buy Imatinib 100 mg and 400 mg Tablets online from India through THE INDIAN PHARMA (a trusted Imatinib Supplier, Exporter, and Contract Manufacturer in India) for the management and treatment of:- Newly diagnosed Ph+ CML (chronic phase) in adults and children
- Ph+ CML in blast crisis, accelerated phase, or post-interferon failure
- Relapsed/refractory Ph+ ALL in adults
- Newly diagnosed Ph+ ALL in children (with chemotherapy)
- Myelodysplastic/Myeloproliferative Diseases (MDS/MPD) with PDGFR gene rearrangements in adults
- Aggressive Systemic Mastocytosis (ASM) without D816V c-Kit mutation or unknown status
- Hypereosinophilic syndrome/Chronic eosinophilic leukemia (HES/CEL) with or without FIP1L1-PDGFRα mutation in adults
- Unresectable, recurrent, or metastatic dermatofibrosarcoma protuberans (DFSP) in adults
- Unresectable/metastatic Kit-positive gastrointestinal stromal tumors (GIST)
- Adjuvant treatment post-resection of Kit-positive gastrointestinal stromal tumors (GIST) in adults
Imatinib 100 mg/400 mg belongs to a class of cancer medications known as tyrosine kinase inhibitors. It helps adults and children suffering from chronic myeloid leukemia (CML). CML is a kind of blood cancer where certain types of white blood cells (WBCs) multiply uncontrollably. It is also indicated for patients with Ph+ acute lymphoblastic leukemia (Ph+ ALL), which is another form of aggressive blood cancer. Besides leukemia, this drug also helps manage some gastrointestinal stromal tumors (GIST). These tumors are rare in that they develop in the walls of the digestive tract and have the potential to metastasize.
Imatinib 100 mg/400 mg tablets are also widely used in the management of myelodysplastic/myeloproliferative syndromes (MDS/MPD)—a collection of disorders where blood cell production is dysregulated. This oral therapeutic drug is also effective in treating patients with hypereosinophilia syndrome (HES) and chronic eosinophilic leukaemia (CEL). These are diseases characterized by excessive production of eosinophils (a type of white blood cell) within the body. This drug is also used for a rare type of cancer, dermatofibrosarcoma protuberans (DFSP), which affects subcutaneous tissue. The medicine acts by inhibiting the progression of pathological cells.
If you’re allergic to Imatinib 100 mg/400 mg or any components of this medicine, do not take it. Also, notify your doctor if you have any issues relating to your heart, liver, or kidneys before treatment. Moreover, notify your doctor if your thyroid is castrated and if you have any kind of thyroid problems. Inform your healthcare professional if acquiring Hepatitis B is possible in your case, as this drug might trigger the disease.
Take care of all the directives from your healthcare professional (HCP). Report any cases of easy bruising, fever, excessive tiredness, abnormal bleeding, or even confusion, as these might be side effects. Additionally, this treatment may impact your fertility, so consult your doctor if this is an issue before starting the treatment.
Dosage & Side Effects:
The recommended dosage of Imatinib should be taken with a meal and a large glass of water. Doses of 400 mg or 600 mg should be administered once daily, whereas a dose of 800 mg should be administered as 400 mg twice daily. This medicine can be dissolved in water or apple juice for patients having difficulty swallowing. Daily dosing of 800 mg or more needs to be accomplished through the 400-mg tablet to reduce exposure to iron.- Adults with Ph+ CML CP: 400 mg/day
- Adults with Ph+ CML AP or BC: 600 mg/day
- Pediatrics with Ph+ CML CP: 340 mg/m2 /day
- Adults with Ph+ ALL: 600 mg/day
- Pediatrics with Ph+ ALL: 340 mg/m2 /day
- Adults with MDS/MPD: 400 mg/day
- Adults with ASM: 100 mg/day or 400 mg/day
- Adults with HES/CEL: 100 mg/day or 400 mg/day
- Adults with DFSP: 800 mg/day
- Adults with metastatic and/or unresectable GIST: 400 mg/day
- Adjuvant treatment of adults with GIST: 400 mg/day
- Patients with mild to moderate hepatic impairment: 400 mg/day
- Patients with severe hepatic impairment: 300 mg/day
The most common side effects of Imatinib 100 mg and 400 mg oral tablets are fatigue, edema, diarrhea, musculoskeletal pain, nausea, vomiting, rash, muscle cramps, and abdominal pain.